Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Pulse Biosciences CS (PLSE)

Pulse Biosciences CS (PLSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,106,076
  • Shares Outstanding, K 61,517
  • Annual Sales, $ 0 K
  • Annual Income, $ -42,210 K
  • EBIT $ -49 M
  • EBITDA $ -47 M
  • 60-Month Beta 1.78
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 13.98

Options Overview Details

View History
  • Implied Volatility 125.21% ( +30.78%)
  • Historical Volatility 80.34%
  • IV Percentile 78%
  • IV Rank 43.12%
  • IV High 276.61% on 05/01/24
  • IV Low 10.42% on 10/10/24
  • Put/Call Vol Ratio 0.04
  • Today's Volume 117
  • Volume Avg (30-Day) 123
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 2,946
  • Open Int (30-Day) 2,955

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.35 +7.27%
on 12/10/24
21.80 -19.55%
on 11/29/24
-0.14 (-0.80%)
since 11/22/24
3-Month
14.06 +24.74%
on 11/01/24
21.80 -19.55%
on 11/29/24
+0.22 (+1.26%)
since 09/23/24
52-Week
6.59 +165.94%
on 04/25/24
22.69 -22.70%
on 08/23/24
+4.88 (+38.54%)
since 12/22/23

Most Recent Stories

More News
Insider Purchase: Director at $PLSE (PLSE) Buys 50,000 Shares

ROBERT W DUGGAN, a director at $PLSE ($PLSE), bought 50,000 shares of the company on 12-11-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their...

PLSE : 17.43 (-3.06%)
Pulse Biosciences, Inc. Appoints Dr. Gan Dunnington as Chief Medical Officer

Pulse Biosciences, Inc. (Nasdaq: PLSE), Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary nanosecond pulsed field ablation (nsPFAâ„¢) technology for the treatment of...

PLSE : 17.43 (-3.06%)
Pulse Biosciences Announces $65 Million Private Placement

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary nanosecond pulsed field ablation (nsPFA™) technology and proprietary CellFX System® for the treatment of atrial...

PLSE : 17.43 (-3.06%)
Pulse Biosciences Schedules First Quarter 2023 Financial Results Conference Call for May 11, 2023

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary nanosecond pulsed field ablation (nsPFAâ„¢) technology for electrophysiology and the treatment of atrial fibrillation,...

PLSE : 17.43 (-3.06%)
Pulse Biosciences Reports Fourth Quarter & Full Year 2022 Financial Results

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary nanosecond pulsed field ablation (nsPFAâ„¢) technology for electrophysiology and the treatment of atrial fibrillation,...

PLSE : 17.43 (-3.06%)
Pulse Biosciences Schedules Fourth Quarter & Full Year 2022 Financial Results Conference Call for March 30, 2023

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary nanosecond pulsed field ablation (nsPFAâ„¢) technology for electrophysiology and the treatment of atrial fibrillation,...

PLSE : 17.43 (-3.06%)
Pulse Biosciences Announces Its Novel Nanosecond Pulsed Field Ablation System Will Be Highlighted at the 2023 AF Symposium

Pulse Biosciences, Inc . (Nasdaq: PLSE), a company leveraging its novel and proprietary nanosecond pulsed field ablation (nsPFAâ„¢) technology for electrophysiology and the treatment of atrial fibrillation,...

PLSE : 17.43 (-3.06%)
Pulse Biosciences Reports Third Quarter 2022 Financial Results

Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company and creator of the unique CellFX® System which harnesses and effectively controls the application of Nano-Pulse Stimulation™...

PLSE : 17.43 (-3.06%)
Pulse Biosciences Schedules Third Quarter 2022 Financial Results Conference Call for November 10, 2022

Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, announced today it will report...

PLSE : 17.43 (-3.06%)
Pulse Biosciences Announces Positive Clinical Data on Nano-Pulse Stimulation Procedure for Low-Risk Basal Cell Carcinoma Lesions

Pulse Biosciences, Inc . (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, today announced positive clinical...

PLSE : 17.43 (-3.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Pulse Biosciences, Inc. is a medical device company. It is engaged in developing a novel and proprietary tissue treatment platform using Nano-Pulse Electro-Signaling. NPES provide effective local tumor control and to initiate an adaptive immune response. The company deploy NPES platform applications...

See More

Key Turning Points

3rd Resistance Point 19.54
2nd Resistance Point 19.04
1st Resistance Point 18.51
Last Price 17.43
1st Support Level 17.48
2nd Support Level 16.97
3rd Support Level 16.44

See More

52-Week High 22.69
Last Price 17.43
Fibonacci 61.8% 16.54
Fibonacci 50% 14.64
Fibonacci 38.2% 12.74
52-Week Low 6.59

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar